Remission of type 2 diabetes one year after esophagectomy with gastric conduit reconstruction: A prospective cohort study

Table 2 Baseline characteristics of patients with and without remission of type 2 diabetes after esophagectomy and gastric conduit reconstruction

Characteristics	Without T2D remission	With T2D remission	P value
Age, years	67.0 ± 6.1	63.0 ± 5.2	0.002
Sex, male (%)	88.5	80.0	0.232
Histology type, squamous cell carcinoma (%)	84.0	91.7	0.329
Pathology stage, I/II (%)	57.1	58.3	0.906
Neoadjuvant therapy (%)	28.2	33.3%	0.606
Surgery procedure, McKeown (%)	84.0	75.0	0.272
Anastomosis leak (%)	8.6	8.3	1.000
Adjuvant therapy (%)	48.5	50.0	0.888
Duration of T2D, years	7.1 ± 3.7	4.9 ± 3.9	0.008
Treatment of T2D, with insulin (%)	17.2	16.7	1.000
Body weight, kg	61.2 ± 9.3	68.6 ± 11.1	0.001
BMI, kg/m2	23.8 ± 3	25.5 ± 2.4	0.011
Fasting glucose before surgery	7.7 ± 1.9	8.1 ± 2.1	0.379
HbA1c before surgery (%)	7.7 ± 1.3	8.5 ± 1.7	0.042

T2D: Type 2 diabetes; BMI: Body mass index; HbA1c: Glycated hemoglobin.